ArticleScientific reports2026
A diagnostic model for discrimination between Pneumocystis jirovecii pneumonia and colonization based on multiple parameters.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Distinguishing Pneumocystis jirovecii pneumonia (PJP) from colonization (PJC) is crucial due to overlapping symptoms but different treatments. This study aims to evaluate whether peripheral blood parameters can serve as a non-invasive tool for distinguishing PJP from PJC. We retrospectively enrolled 174 patients with PJP and 61 with PJC from the First Affiliated Hospital of Sun Yat-sen University (April 2022-March 2024). Peripheral blood parameters were analyzed and compared between groups. Normally distributed variables were assessed using Student's t-test, while non-parametric data were analyzed with the Wilcoxon rank-sum test. A diagnostic model was subsequently developed based on significant hematological indicators. Utilizing a significance threshold of p < 0.05, red blood cell (RBC) and lymphocyte percentage (Lym%), while excluding neutrophil percentage (Neu%), procalcitonin (PCT), and lactic dehydrogenase (LDH) were used to build a random forest diagnostic model. The optimal XGBoost model achieved an AUC of 0.9991 internally and 0.787 in external validation. A web-based tool was developed to assist diagnosis. The findings of this study offer an effective tool for clinical practice, enabling physicians to accurately diagnose and differentiate between PJP and PJC, guiding appropriate treatment for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.